Symphogen publishes discovery and pre-clinical data on first chicken-derived antibody to enter human clinical trials

Ads

You May Also Like

National Cancer Institute selects Apexian Pharmaceuticals to participate in the Small Business Innovation Research (SBIR) Initiative program

Indianapolis, Indiana, USA, Sept. 27, 2017 (GLOBE NEWSWIRE) --                                                                                                                                           FOR IMMEDIATE RELEASE National ...